Eli Lilly Escapes Testosterone MDL With Settlement Deal

By Emily Field (December 22, 2017, 3:54 PM EST) -- Eli Lilly & Co. told an Illinois federal judge on Thursday it had reached a global settlement in all cases filed against the pharmaceutical company in multidistrict litigation over testosterone replacement therapy products, striking the deal about a month before the company's first bellwether trial.

Eli Lilly and the consumers told U.S. District Judge Matthew Kennelly that they had entered into a memorandum of understanding, according to a court order. The judge cancelled two upcoming trial dates in January and March over Tracy Garner and John DeBroka Jr.'s cases alleging that Eli Lilly's Axiron caused them to suffer from a heart...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read the full article

Already a subscriber? Click here to login